PALISADE BIO, INC. (PALI) Operating margin 2016–2023
PALISADE BIO, INC. (PALI) operating margin by fiscal year — reported operating income divided by reported revenue.
-5228.0%FY2023 · since FY2016: -127027.2% → -5228.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -5228.0% | — |
| FY2020 | -68764.8% | -12693.0 pp |
| FY2019 | -56071.8% | -52895.1 pp |
| FY2018 | -3176.7% | +1941.4 pp |
| FY2017 | -5118.1% | +121909.1 pp |
| FY2016 | -127027.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More PALI financial trends
PALI RevenuePALI Net incomePALI Net marginPALI Gross profitPALI Gross marginPALI Operating incomePALI Operating cash flowPALI Free cash flowPALI Capital expendituresPALI Return on equityPALI Stock buybacksPALI Dividends paidPALI Total assetsPALI Total liabilitiesPALI Shareholders’ equityPALI overview →